GlassScriptPhysician profile
David B Leung
NPI 1902297708
$3,163.16
in general payments reported to CMS, 2019-2025
17 companies · $732 in 2025
The $732 reported for 2025 was more than what 81% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,278 · 2022: $111 · 2023: $645 · 2024: $398 · 2025: $732.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,766 · Education: $7.96.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,766.29 |
| Education | $7.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gemini Mountain Medical, LLC | $1,286.77 | 2021-2025 | |
| Stryker Corporation | $685.30 | 2021-2025 | Axsos, T2, Sps |
| Amgen INC. | $358.03 | 2023-2025 | Evenity, Prolia |
| Ucb, INC. | $185.61 | 2021-2023 | |
| Radius Health, INC. | $180.28 | 2021-2025 | Tymlos |
| Globus Medical, INC. | $133.12 | 2023 | Tibial Nail, Proximal Femur, Cerclage Cable Fixation |
| Heron Therapeutics, INC. | $83.92 | 2025 | Zynrelef |
| Bioventus LLC | $43.50 | 2024-2025 | Xcell, Durolane |
| Medacta USA, INC. | $36.59 | 2025 | Reverse Shoulder |
| Anika Therapeutics, INC. | $30.45 | 2024 | Ovo Motion, Revomotion |
| Davol INC. | $28.51 | 2022 | |
| Ossur Americas, INC. | $23.54 | 2024 | |
| Convatec INC. | $23.16 | 2021 | |
| Kerecis Limited | $17.08 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Becton, Dickinson and Company | $16.96 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $16.24 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Ferring Pharmaceuticals INC. | $14.10 | 2023 | Rebyota |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Leung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.